Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Medical Industry Today.
Press releases published on May 30, 2025
Introducing a body sponge modeled after the Japanese food himono
EIN Presswire
·
May 30, 2025
HAKUSAN, JAPAN, May 30, 2025 /EINPresswire.com/ -- Faith Co., Ltd., based in Hakusan City, Ishikawa Prefecture, is excited to introduce the "Himono Sponge," a unique bath item that resembles a traditional Japanese dried fish, or "himono." This product is …
COSCIENS Biopharma Inc. Reconstitutes Board for Benefit of Shareholders
GlobeNewswire
·
May 30, 2025
Reconstituted Board to Revitalize COSCIENS TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI; TSX: CSCI) today announced that it has entered into a resolution agreement (the “Resolution Agreement”) with Goodwood Inc., Goodwood …
The London Clinic is the first independent hospital to offer GALEAS™ bladder cancer tests
EIN Presswire
·
May 30, 2025
May is Bladder Cancer Awareness Month and this test, which is supported by charity Action Bladder Cancer, could reduce suffering for thousands of patients. BIRMINGHAM, WEST MIDLANDS, UNITED KINGDOM, May 30, 2025 /EINPresswire.com/ -- Nonacus Clinical …
Microbial pioneers: how bacteria shape dental implant health from day one
EIN Presswire
·
May 30, 2025
GA, UNITED STATES, May 30, 2025 /EINPresswire.com/ -- A new study suggests that the earliest microbes to colonize a dental implant may determine its long-term fate. Using high-resolution genomic sequencing and a 12-week clinical timeline, scientists …
Fate Therapeutics Appoints Matthew Abernethy, M.B.A., to its Board of Directors
GlobeNewswire
·
May 30, 2025
SAN DIEGO, May 30, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf cellular immunotherapies to …
Cornerstone of Southern California Treatment Center Announces New Ownership and Vision for the Future of Recovery Care
EIN Presswire
·
May 30, 2025
Cornerstone of Southern California is under new ownership and will continue providing transformational and life-changing substance use disorder treatment. SANTA ANA, CA, UNITED STATES, May 30, 2025 /EINPresswire.com/ -- Cornerstone of Southern …
Publication relating to transparency notifications
GlobeNewswire
·
May 30, 2025
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), May 30, 2025, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large …
Publication relative à des notifications de transparence
GlobeNewswire
·
May 30, 2025
INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert (Belgique), le 30 mai 2025, 22:30h CET / 16:30h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative à la publicité des participations …
Plus Therapeutics Reports First Quarter Financial Results and Recent Business Highlights
GlobeNewswire
·
May 30, 2025
Company continues to progress both REYOBIQ™ radiotherapeutic clinical trials and CNSide® CSF assay platform launch readiness HOUSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage …
NurExone Announces Clinical Trial Plans for Acute Spinal Cord Injury Therapy at Annual Meeting of American Spinal Injury Association
GlobeNewswire
·
May 30, 2025
TORONTO and HAIFA, Israel, May 30, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce that Professor Nahshon Knoller M.D., senior clinical advisor to the Company, will …
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 30, 2025
VANCOUVER, British Columbia and BOSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …
Kymera Therapeutics to Announce KT-621 Phase 1 Healthy Volunteer Trial Results on June 2, 2025
GlobeNewswire
·
May 30, 2025
WATERTOWN, Mass., May 30, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, will announce results from …
24-Year-Old Startup Founder Named One of New Jersey’s Top 100 Innovators
EIN Presswire
·
May 30, 2025
House Call The App Founder, Rose Biedron, has been honored as one of New Jersey’s Top 100 Innovators To Watch for 2025 by Innovate100 PALM BEACH COUNTY, FL, UNITED STATES, May 30, 2025 /EINPresswire.com/ -- House Call The App proudly announces that its …
R3 Stem Cell Publishes Research Paper on Safety of Intravenous Mesenchymal Stem Cell Therapy
EIN Presswire
·
May 30, 2025
SCOTTSDALE, AZ, UNITED STATES, May 29, 2025 /EINPresswire.com/ -- R3 Stem Cell, the global leader in regenerative therapies, recently published a research paper titled, “Safety of intravenous mesenchymal stem cell therapy: a meta-analysis of randomized …
Tevogen Details its Artificial Intelligence Initiative, Tevogen.AI; Proprietary AI-Powered Immunotherapy with Microsoft and Databricks Partnerships
GlobeNewswire
·
May 30, 2025
WARREN, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today provided stockholders with a detailed overview of its artificial intelligence initiative, Tevogen.AI™. Tevogen.AI™ aims to integrate …
America’s Blood Centers and ACS Stop the Bleed Announce New National Collaboration
GlobeNewswire
·
May 30, 2025
Washington, DC, May 30, 2025 (GLOBE NEWSWIRE) -- America’s Blood Centers (ABC), the national organization of community-based, independent blood centers that supply 60 percent of the nation’s blood supply, and the American College of Surgeons (ACS) Stop the …
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics
GlobeNewswire
·
May 30, 2025
MIAMI, May 30, 2025 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity …
Legend Senior Living® Grows Portfolio Across Kansas, Colorado, and Pennsylvania
GlobeNewswire
·
May 30, 2025
WICHITA, Kan., May 30, 2025 (GLOBE NEWSWIRE) -- Legend Senior Living, a national senior housing provider headquartered in Wichita, Kansas, has announced it will assume management of four additional communities, expanding its growing portfolio. The …
Canadian Vaping Association Highlights Plans to Reduce Youth Vaping Rates on World Vape Day
GlobeNewswire
·
May 30, 2025
Ottawa, ON, May 30, 2025 (GLOBE NEWSWIRE) -- On World Vape Day, the Canadian Vaping Association (CVA) celebrates the continued decline in youth vaping rates, as reported in Statistics Canada’s 2025 Canadian Health Survey on Children and Youth (published …
PharmAla Biotech Warns Against Fake Products Claiming to be Made by PharmAla
GlobeNewswire
·
May 30, 2025
TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA ( …